New bandage tested for leg ulcer healing

NCT ID NCT07600489

Not yet recruiting Disease control Sponsor: Molnlycke Health Care AB Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares two types of compression bandages for treating venous leg ulcers, which are slow-healing wounds on the lower leg. About 386 adults will receive either the new Mepi Press 2 or the standard UrgoK2 bandage for up to 12 weeks. The goal is to see if the new bandage works as well at healing the ulcers completely.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Compression bandage system (Mepi Press 2)
What this could lead to: If successful, this could offer a new, equally effective option for treating venous leg ulcers with compression therapy.
What could go wrong: This is a non-inferiority trial comparing two existing devices, so no major breakthrough is expected. Results may show similar effectiveness, not superiority.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COMPRESSION BANDAGES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ulcer of lower limbs Varicose Ulcer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COMPRESSION BANDAGES VENOUS LEG ULCER (VLU)

Contacts and locations

Show contact details

Locations

CHU Michallon Grenoble

Grenoble, France
CHU Nantes

Nantes, France
CHU Toulouse/Hopital Rangueil

Toulouse, France
Clinique Pasteur-Toulouse

Toulouse, France
Clinique du Parc Lyon

Lyon, France

Contact Email: •••••@•••••
Clinique du Parc-Montpellier

Castelnau-le-Lez, France
Hopital Edouard Herriot_HCL

Lyon, France
Poitiers Polyclinique

Poitiers, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.